Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Buck

Showing results (301-310 of 400) with videos related to

Pageof 40
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|April 1, 2010
First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECTThomas Wendler, Ken Herrmann, Andreas Schnelzer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2022
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell LymphomaAndreas K Buck, Götz Ulrich Grigoleit, Sabrina Kraus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell TransplantationSabine Maurer, Peter Herhaus, Romina Lippenmeyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2016
Synthesis and preclinical evaluation of an Al<sup>18</sup>F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligandStefano Boschi, Jason T Lee, Seval Beykan, et al.
Brain : a Journal of Neurology|September 24, 2016
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?Martin M Reich, Joachim Brumberg, Nicolò G Pozzi, et al.
Clinical Nuclear Medicine|March 22, 2023
Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and TherapyPhilipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, et al.
Molecular Imaging and Biology|August 16, 2008
Imaging proliferation to monitor early response of lymphoma to cytotoxic treatmentNicolas Graf, Ken Herrmann, Jürgen den Hollander, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2018
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization FrameworkRudolf A Werner, Lilja B Solnes, Mehrbod S Javadi, et al.
EJNMMI Research|January 9, 2014
18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repairMarielle J Wondergem, Ken Herrmann, Sergei Syrbu, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 29, 2023
Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [<sup>18</sup>F]FDGYingjun Zhi, Rudolf A Werner, Andreas Schirbel, et al.
Pageof 40

Showing results (301-310 of 400) with videos related to

Sort By:
Pageof 40
European Journal of Nuclear Medicine and Molecular Imaging|April 1, 2010
First demonstration of 3-D lymphatic mapping in breast cancer using freehand SPECTThomas Wendler, Ken Herrmann, Andreas Schnelzer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 23, 2022
C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell LymphomaAndreas K Buck, Götz Ulrich Grigoleit, Sabrina Kraus, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Side Effects of CXC-Chemokine Receptor 4-Directed Endoradiotherapy with Pentixather Before Hematopoietic Stem Cell TransplantationSabine Maurer, Peter Herhaus, Romina Lippenmeyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 23, 2016
Synthesis and preclinical evaluation of an Al<sup>18</sup>F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligandStefano Boschi, Jason T Lee, Seval Beykan, et al.
Brain : a Journal of Neurology|September 24, 2016
Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?Martin M Reich, Joachim Brumberg, Nicolò G Pozzi, et al.
Clinical Nuclear Medicine|March 22, 2023
Interobserver Agreement Rates on C-X-C Motif Chemokine Receptor 4-Directed Molecular Imaging and TherapyPhilipp E Hartrampf, Aleksander Kosmala, Sebastian E Serfling, et al.
Molecular Imaging and Biology|August 16, 2008
Imaging proliferation to monitor early response of lymphoma to cytotoxic treatmentNicolas Graf, Ken Herrmann, Jürgen den Hollander, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 25, 2018
SSTR-RADS Version 1.0 as a Reporting System for SSTR PET Imaging and Selection of Potential PRRT Candidates: A Proposed Standardization FrameworkRudolf A Werner, Lilja B Solnes, Mehrbod S Javadi, et al.
EJNMMI Research|January 9, 2014
18 F-fluorothymidine uptake in follicular lymphoma and error-prone DNA repairMarielle J Wondergem, Ken Herrmann, Sergei Syrbu, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 29, 2023
Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [<sup>18</sup>F]FDGYingjun Zhi, Rudolf A Werner, Andreas Schirbel, et al.
Pageof 40